PE-041 Impact associated with pertuzumab and trastuzumab SC and IV formulations utilization in metastatic HER2- positive breast cancer patients treated in SUS
Introduction: Current gold standard therapy for metastatic breast cancer (mBC) HER2-positive patients – double blockage with pertuzumab and trastuzumab (P+T) – is available in the Sistema Único de Saúde (SUS) as intravenous (IV) formulations. Despite important clinical and economic benefits that th...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Instituto Nacional de Assistência Farmacêutica e Farmacoeconomia
2025-03-01
|
| Series: | Jornal de Assistência Farmacêutica e Farmacoeconomia |
| Subjects: | |
| Online Access: | https://www.ojs.jaff.org.br/ojs/index.php/jaff/article/view/1152 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!